newsfilter
← Latest News
Business Wire·

PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology

Company prepares for comprehensive discussion with FDA to determine appropriate next steps for technology while evaluating additional opportunities PharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the